ciprofloxacin has been researched along with ropocamptide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andersson, DI; Negrea, A; Pränting, M; Rhen, M | 1 |
| Kamal, N; Shafer, WM | 1 |
| Kumar, SD; Rajasekaran, G; Shin, SY; Yang, S | 1 |
3 other study(ies) available for ciprofloxacin and ropocamptide
| Article | Year |
|---|---|
Mechanism and fitness costs of PR-39 resistance in Salmonella enterica serovar Typhimurium LT2.
Topics: Animals; Anti-Bacterial Agents; Antimicrobial Cationic Peptides; Bacterial Proteins; Cathelicidins; Drug Resistance, Multiple, Bacterial; Female; Genetic Complementation Test; Mice; Mice, Inbred BALB C; Microbial Sensitivity Tests; Models, Genetic; Mutagenesis, Insertional; Mutation; Salmonella Infections, Animal; Salmonella typhimurium; Sequence Deletion | 2008 |
Biologic activities of the TolC-like protein of Neisseria meningitidis as assessed by functional complementation in Escherichia coli.
Topics: Anti-Bacterial Agents; Bacterial Proteins; Escherichia coli; Escherichia coli Proteins; Genetic Complementation Test; Hemolysin Proteins; Humans; Microbial Sensitivity Tests; Neisseria meningitidis | 2010 |
The design of a cell-selective fowlicidin-1-derived peptide with both antimicrobial and anti-inflammatory activities.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Cathelicidins; Cell Survival; Chickens; Dose-Response Relationship, Drug; Drug Design; Erythrocytes; Gram-Negative Bacteria; Gram-Positive Bacteria; Mice; Microbial Sensitivity Tests; Molecular Structure; Peptide Fragments; RAW 264.7 Cells; Sheep; Structure-Activity Relationship | 2019 |